What Researchers Did
Researchers studied 90 patients with post-stroke depression to see how hyperbaric oxygen therapy, fluoxetine medication, or a combination of both affected their symptoms over four weeks.
What They Found
All three groups showed significant reductions in Hamilton Depression Scale (HAMD) and Scandinavian Stroke Scale (SSS) scores after four weeks of treatment. Patients receiving combined hyperbaric oxygen therapy (once a day, 5 days/week) and fluoxetine medication demonstrated a higher overall effective rate for depression relief compared to those receiving either treatment alone.
What This Means for Canadian Patients
For Canadian patients experiencing post-stroke depression, this study suggests that combining hyperbaric oxygen therapy with standard antidepressant medication like fluoxetine could be more effective than either treatment alone. This approach might offer an improved path to managing depression symptoms following a stroke, potentially enhancing overall recovery.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. Post-stroke depression is not a Health Canada-recognized indication for hyperbaric oxygen therapy. Therefore, no direct Canadian connection identified.
Study Limitations
The study involved a relatively small number of patients and a short treatment duration of only four weeks, which may limit the generalizability of the findings.